- Home
- SVIV vs SRZN Comparison
SVIV vs SRZN Comparison
Compare SVIV & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$31.41
Company Overview
Basic Information| Metric | SVIV | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.8M | 276.3M |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SVIV | SRZN |
|---|---|---|
| Price | $10.10 | $31.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $63.50 |
| AVG Volume (30 Days) | 64.1K | ★ 272.4K |
| Earning Date | N/A | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $187.60 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.87 | $12.52 |
| 52 Week High | $10.73 | $37.83 |
Technical Indicators
Market Signals| Indicator | SVIV | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 58.89 |
| Support Level | $10.02 | $22.61 |
| Resistance Level | $10.28 | $33.96 |
| Average True Range (ATR) | 0.04 | 2.22 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 48.48 | 64.30 |
Price Performance
Historical Comparison SVIV
SRZN
About SVIV Spring Valley Acquisition Corp. IV Class A Ordinary Shares
Spring Valley Acquisition Corp IV is a blank check company established for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).